Literature DB >> 28778873

Genetic PrP Prion Diseases.

Mee-Ohk Kim1, Leonel T Takada2, Katherine Wong1, Sven A Forner1, Michael D Geschwind1.   

Abstract

Genetic prion diseases (gPrDs) caused by mutations in the prion protein gene (PRNP) have been classified as genetic Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker disease, or fatal familial insomnia. Mutations in PRNP can be missense, nonsense, and/or octapeptide repeat insertions or, possibly, deletions. These mutations can produce diverse clinical features. They may also show varying ancillary testing results and neuropathological findings. Although the majority of gPrDs have a rapid progression with a short survival time of a few months, many also present as ataxic or parkinsonian disorders, which have a slower decline over a few to several years. A few very rare mutations manifest as neuropsychiatric disorders, with systemic symptoms that include gastrointestinal disorders and neuropathy; these forms can progress over years to decades. In this review, we classify gPrDs as rapid, slow, or mixed types based on their typical rate of progression and duration, and we review the broad spectrum of phenotypes manifested by these diseases.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28778873      PMCID: PMC5932589          DOI: 10.1101/cshperspect.a033134

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  208 in total

1.  Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene.

Authors:  Neeraj Kumar; Bradley F Boeve; Brendon P Boot; Carolyn F Orr; Joseph Duffy; Bryan K Woodruff; Anil K Nair; Jay Ellison; Karen Kuntz; Kejal Kantarci; Clifford R Jack; Barbara F Westmoreland; Julie A Fields; Matthew Baker; Rosa Rademakers; Joseph E Parisi; Dennis W Dickson
Journal:  Arch Neurol       Date:  2011-09

2.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Abnormal properties of prion protein with insertional mutations in different cell types.

Authors:  S A Priola; B Chesebro
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

4.  Novel PRNP sequence variant associated with familial encephalopathy.

Authors:  L Cervenáková; C Buetefisch; H S Lee; I Taller; G Stone; C J Gibbs; P Brown; M Hallett; L G Goldfarb
Journal:  Am J Med Genet       Date:  1999-12-15

5.  Huntington disease phenocopy is a familial prion disease.

Authors:  R C Moore; F Xiang; J Monaghan; D Han; Z Zhang; L Edström; M Anvret; S B Prusiner
Journal:  Am J Hum Genet       Date:  2001-10-09       Impact factor: 11.025

6.  Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Authors:  K Hsiao; Z Meiner; E Kahana; C Cass; I Kahana; D Avrahami; G Scarlato; O Abramsky; S B Prusiner; R Gabizon
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

7.  Gerstmann-Sträussler-Scheinker disease with the Q217R mutation mimicking frontotemporal dementia.

Authors:  John Woulfe; Andrew Kertesz; Inge Frohn; Sharon Bauer; Peter St George-Hyslop; Catherine Bergeron
Journal:  Acta Neuropathol       Date:  2005-07-16       Impact factor: 17.088

8.  A patient with Creutzfeldt-Jakob disease with an insertion of 7 octa-repeats in the PRNP gene: molecular characteristics and clinical features.

Authors:  Yan-Jun Guo; Xiao-Fan Wang; Jun Han; Bao-Yun Zhang; Wei-Qin Zhao; Qi Shi; Yan-Zhen Wan; Chen Gao; Ji-Mei Li; De-Xin Wang; Xiao-Ping Dong
Journal:  Am J Med Sci       Date:  2008-12       Impact factor: 2.378

Review 9.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

10.  A case of dementia with PRNP D178Ncis-129M and no insomnia.

Authors:  Rita J Guerreiro; Tina Vaskov; Cynthia Crews; Andrew Singleton; John Hardy
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

View more
  28 in total

1.  Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

Authors:  Alejandro M Sevillano; Patricia Aguilar-Calvo; Timothy D Kurt; Jessica A Lawrence; Katrin Soldau; Thu H Nam; Taylor Schumann; Donald P Pizzo; Sofie Nyström; Biswa Choudhury; Hermann Altmeppen; Jeffrey D Esko; Markus Glatzel; K Peter R Nilsson; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease.

Authors:  Julia A Callender; Alejandro M Sevillano; Katrin Soldau; Timothy D Kurt; Taylor Schumann; Donald P Pizzo; Hermann Altmeppen; Markus Glatzel; Jeffrey D Esko; Christina J Sigurdson
Journal:  Neurobiol Dis       Date:  2020-05-24       Impact factor: 5.996

3.  Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.

Authors:  Qi Shi; Cao Chen; Kang Xiao; Wei Zhou; Li-Ping Gao; Dong-Dong Chen; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  Neurosci Bull       Date:  2021-09-06       Impact factor: 5.203

Review 4.  Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions.

Authors:  Pakorn Kanchanawong; David A Calderwood
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-27       Impact factor: 113.915

5.  Differential gene expression response of synovial fibroblasts from temporomandibular joints and knee joints to dynamic tensile stress.

Authors:  Ute Nazet; Patrick Neubert; Valentin Schatz; Susanne Grässel; Peter Proff; Jonathan Jantsch; Agnes Schröder; Christian Kirschneck
Journal:  J Orofac Orthop       Date:  2021-06-17       Impact factor: 1.938

6.  An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia.

Authors:  Leonardo Iaccarino; Luca Presotto; Valentino Bettinardi; Luigi Gianolli; Ignazio Roiter; Sabina Capellari; Piero Parchi; Pietro Cortelli; Daniela Perani
Journal:  Ann Clin Transl Neurol       Date:  2017-12-09       Impact factor: 4.511

7.  Case Report: Histopathology and Prion Protein Molecular Properties in Inherited Prion Disease With a De Novo Seven-Octapeptide Repeat Insertion.

Authors:  Ignazio Cali; Laura Cracco; Dario Saracino; Rossana Occhipinti; Cinzia Coppola; Brian Stephen Appleby; Gianfranco Puoti
Journal:  Front Cell Neurosci       Date:  2020-07-08       Impact factor: 5.505

8.  Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity.

Authors:  Elsa Ghirardini; Elena Restelli; Raffaella Morini; Ilaria Bertani; Davide Ortolan; Fabio Perrucci; Davide Pozzi; Michela Matteoli; Roberto Chiesa
Journal:  PLoS Pathog       Date:  2020-07-16       Impact factor: 6.823

9.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088

10.  Autoantibodies against the prion protein in individuals with PRNP mutations.

Authors:  Karl Frontzek; Manfredi Carta; Marco Losa; Mirka Epskamp; Georg Meisl; Alice Anane; Jean-Philippe Brandel; Ulrike Camenisch; Joaquín Castilla; Stéphane Haïk; Tuomas Knowles; Ewald Lindner; Andreas Lutterotti; Eric Vallabh Minikel; Ignazio Roiter; Jiri G Safar; Raquel Sanchez-Valle; Dana Žáková; Simone Hornemann; Adriano Aguzzi
Journal:  Neurology       Date:  2020-02-25       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.